Teva to Acquire Theramex, Merck KGaA’s European Based Women’s Health Business
Theramex is speciality pharmaceutical company focused on Women health and markets various products, like gynecology, osteoporosis, peri-menopause, menopause and contraceptives, in more than 50 countries. Theramex is developing new contraceptive combination of “nomegestrol acetate (2.5mg)/17beta-estradiol (1.5mg)”
Pimavanserin is selectively blocks serotonin 5-HT2A receptors in Phase III development for treating Parkinson’s disease psychosis
The patent infringement action was filed in the U.S. District Court for the District of New Jersey on October 27, 2010 requesting, among other things, an order that the date of approval of Nycomed’s ANDA not be earlier than the expiration of Astellas’ U.S. Patent Nos. 5,665,727 and 5,385,907 related to Protopic.